WM983BBR Viable Cells

Catalog Number: ROC-WM983BBR-01-0005
Article Name: WM983BBR Viable Cells
Biozol Catalog Number: ROC-WM983BBR-01-0005
Supplier Catalog Number: WM983BBR-01-0005
Alternative Catalog Number: ROC-WM983BBR-01-0005
Manufacturer: Rockland Immunochemicals
Category: Zellen/Zellkultur
Conjugation: Unconjugated
Alternative Names: Melanoma, patient derived tumor, tumor models, skin cancer, xenograft
WM983BBR is a human metastatic melanoma cell line that displays a mesenchymal morphology. The WM983BBR cell line contains the BRAF V600E mutation that causes increased signaling via the extracellular signal-regulated MAPK/ERK kinase pathways to enhance proliferation. WM983BBR is wild type for PTEN, N-ras, c-KIT, and CDK4. This cell line was derived from the same patient as the cell lines WM983A, WM983B, and WM983C. The WM983BBR cells produce xenograft tumors when injected into immunocompromised mice.
Concentration: 1.0 million cells/mL (Count By Hemocytometer)
Buffer: None
Source: Human
Form: Frozen Cell Suspension
Application Notes: The key applications of these cell lines include genetic studies, xenograft production, drug testing, and drug target discovery. These cell line models can be used in various biological assays, and for identifying critical target genes, and cell signaling pathways.
Human melanoma tumor cells with known gene mutations, disease stage, STR, and RPPA profiling